✦ LIBER ✦

Economic evaluation of gemcitabine single agent therapy compared with standard treatment in stage IIIB and IV non-small cell lung cancer

✍ Scribed by Gunnel Ragnarson Tennvall; Jan-Olof Fernberg

Book ID: 105678050
Publisher: Springer US
Year: 1998
Tongue: English
Weight: 978 KB
Volume: 15
Category: Article
ISSN: 1357-0560
DOI: 10.1007/bf02989592

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Single agent gemcitabine in the second-l

Single agent gemcitabine in the second-line treatment of advanced non-small cell lung cancer after treatment with taxane + platinum regimens

✍ Ugur Coskun; Ali Osman Kaya; Süleyman Buyukberber; Mustafa Benekli; Aytug Uner; 📂 Article 📅 2007 🏛 Springer US 🌐 English ⚖ 147 KB

Combination versus sequential single-age

Combination versus sequential single-agent chemotherapy in the treatment of patients with advanced non-small cell lung cancer

✍ Niell, Harvey B. ;Griffin, John P. ;Hunter, Robert F. ;Meredith, Charlotte A. ;S 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 716 KB

We have carried out a randomized phase Ill study in 105 patients with advanced nonsmall cell lung cancer, comparing a fourdrug cisplatin-mitomycin-based combination chemotherapy regimen t o sequential single-agent therapy. The combination chemotherapy regimen consisted of mitomycin C (10 mg/m2), vin

Phase I/II study of cisplatin, ifosfamid

Phase I/II study of cisplatin, ifosfamide and irinotecan with rhG-CSF support in patients with stage IIIB and IV non-small-cell lung cancer

✍ Akihisa Fujita; Hirotsugu Takabatake; Shigeru Tagaki; Kyuhichiro Sekine 📂 Article 📅 2000 🏛 Springer 🌐 English ⚖ 80 KB

Phase I/II Trial of Docetaxel and Carbop

Phase I/II Trial of Docetaxel and Carboplatin as a First-Line Therapy in Patients with Stage IV Non-Small-Cell Lung Cancer

✍ Kensuke Kataoka; Ryujiro Suzuki; Hiroyuki Taniguchi; Yasunobu Noda; Joe Shindoh; 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 82 KB

Randomized phase II evaluation of preope

Randomized phase II evaluation of preoperative radiation therapy (XRT) and chemotherapy with mitomycin-C, vinblastine, and cisplatin (MVP) for patients with pathologic stage IIIA and IIIB non-small cell lung cancer (NSCLC)

✍ Henry Wagner Jr.; Thomas Lad; John C. Ruckdeschel 📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 118 KB

Phase II study of neoadjuvant chemothera

Phase II study of neoadjuvant chemotherapy and radiation therapy with thoracotomy in the treatment of clinically staged IIIA non-small cell lung cancer

✍ Margaret Deutsch; Jeffrey Crawford; Kenneth Leopold; Walter Wolfe; William Foste 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 939 KB